科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2011/08/12 | 1,075 | 1,079 | 1,067 | 1,074 | +9 | +0.8% | 303,000 |
| 2011/08/11 | 1,053 | 1,070 | 1,050 | 1,065 | +12 | +1.1% | 380,000 |
| 2011/08/10 | 1,055 | 1,061 | 1,049 | 1,053 | +1 | +0.1% | 425,000 |
| 2011/08/09 | 1,025 | 1,054 | 1,017 | 1,052 | +7 | +0.7% | 564,000 |
| 2011/08/08 | 1,040 | 1,055 | 1,035 | 1,045 | +7 | +0.7% | 595,000 |
| 2011/08/05 | 1,045 | 1,047 | 1,026 | 1,038 | -27 | -2.5% | 529,000 |
| 2011/08/04 | 1,060 | 1,077 | 1,057 | 1,065 | +3 | +0.3% | 273,000 |
| 2011/08/03 | 1,070 | 1,077 | 1,061 | 1,062 | -25 | -2.3% | 394,000 |
| 2011/08/02 | 1,090 | 1,090 | 1,085 | 1,087 | -7 | -0.6% | 209,000 |
| 2011/08/01 | 1,089 | 1,109 | 1,089 | 1,094 | +5 | +0.5% | 256,000 |
| 2011/07/29 | 1,108 | 1,108 | 1,088 | 1,089 | -17 | -1.5% | 375,000 |
| 2011/07/28 | 1,104 | 1,113 | 1,100 | 1,106 | -5 | -0.5% | 294,000 |
| 2011/07/27 | 1,124 | 1,124 | 1,104 | 1,111 | -11 | -1% | 325,000 |
| 2011/07/26 | 1,119 | 1,136 | 1,118 | 1,122 | +8 | +0.7% | 443,000 |
| 2011/07/25 | 1,105 | 1,120 | 1,102 | 1,114 | +13 | +1.2% | 358,000 |
| 2011/07/22 | 1,100 | 1,105 | 1,093 | 1,101 | +4 | +0.4% | 390,000 |
| 2011/07/21 | 1,106 | 1,106 | 1,094 | 1,097 | -5 | -0.5% | 186,000 |
| 2011/07/20 | 1,115 | 1,116 | 1,098 | 1,102 | ±0 | ±0% | 377,000 |
| 2011/07/19 | 1,106 | 1,110 | 1,101 | 1,102 | -4 | -0.4% | 300,000 |
| 2011/07/15 | 1,102 | 1,110 | 1,102 | 1,106 | +5 | +0.5% | 353,000 |
| 2011/07/14 | 1,102 | 1,107 | 1,098 | 1,101 | -1 | -0.1% | 132,000 |
| 2011/07/13 | 1,108 | 1,117 | 1,102 | 1,102 | -4 | -0.4% | 337,000 |
| 2011/07/12 | 1,104 | 1,109 | 1,099 | 1,106 | -5 | -0.5% | 440,000 |
| 2011/07/11 | 1,106 | 1,115 | 1,103 | 1,111 | -4 | -0.4% | 279,000 |
| 2011/07/08 | 1,119 | 1,123 | 1,115 | 1,115 | -7 | -0.6% | 292,000 |
| 2011/07/07 | 1,120 | 1,122 | 1,114 | 1,122 | -4 | -0.4% | 176,000 |
| 2011/07/06 | 1,120 | 1,128 | 1,113 | 1,126 | +5 | +0.4% | 217,000 |
| 2011/07/05 | 1,139 | 1,139 | 1,117 | 1,121 | -10 | -0.9% | 313,000 |
| 2011/07/04 | 1,125 | 1,134 | 1,125 | 1,131 | +4 | +0.4% | 260,000 |
| 2011/07/01 | 1,135 | 1,143 | 1,127 | 1,127 | ±0 | ±0% | 300,000 |
| 2011/06/30 | 1,120 | 1,127 | 1,116 | 1,127 | +11 | +1% | 367,000 |
| 2011/06/29 | 1,110 | 1,116 | 1,102 | 1,116 | +17 | +1.5% | 191,000 |
| 2011/06/28 | 1,101 | 1,103 | 1,094 | 1,099 | -2 | -0.2% | 255,000 |
| 2011/06/27 | 1,105 | 1,105 | 1,095 | 1,101 | -14 | -1.3% | 289,000 |
| 2011/06/24 | 1,126 | 1,130 | 1,111 | 1,115 | -11 | -1% | 224,000 |
| 2011/06/23 | 1,115 | 1,131 | 1,114 | 1,126 | +10 | +0.9% | 329,000 |
| 2011/06/22 | 1,138 | 1,139 | 1,098 | 1,116 | -28 | -2.4% | 803,000 |
| 2011/06/21 | 1,144 | 1,154 | 1,136 | 1,144 | -3 | -0.3% | 153,000 |
| 2011/06/20 | 1,136 | 1,157 | 1,136 | 1,147 | +12 | +1.1% | 213,000 |
| 2011/06/17 | 1,165 | 1,176 | 1,135 | 1,135 | -29 | -2.5% | 443,000 |
| 2011/06/16 | 1,179 | 1,179 | 1,164 | 1,164 | -17 | -1.4% | 238,000 |
| 2011/06/15 | 1,179 | 1,183 | 1,174 | 1,181 | +2 | +0.2% | 284,000 |
| 2011/06/14 | 1,165 | 1,185 | 1,164 | 1,179 | +15 | +1.3% | 398,000 |
| 2011/06/13 | 1,174 | 1,174 | 1,160 | 1,164 | -4 | -0.3% | 217,000 |
| 2011/06/10 | 1,162 | 1,175 | 1,157 | 1,168 | +8 | +0.7% | 457,000 |
| 2011/06/09 | 1,156 | 1,161 | 1,148 | 1,160 | +4 | +0.3% | 257,000 |
| 2011/06/08 | 1,147 | 1,157 | 1,143 | 1,156 | +9 | +0.8% | 272,000 |
| 2011/06/07 | 1,158 | 1,158 | 1,146 | 1,147 | -4 | -0.3% | 271,000 |
| 2011/06/06 | 1,145 | 1,158 | 1,144 | 1,151 | +4 | +0.3% | 275,000 |
| 2011/06/03 | 1,163 | 1,163 | 1,143 | 1,147 | -16 | -1.4% | 353,000 |
3351～
3400
件表示中 / 3686件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 413,300円 | +30.5% | +111.0% | 4.60% | 11.65倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 361,300円 | +7.9% | +8.9% | 3.43% | 7.73倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 188,000円 | +5.0% | +1.5% | 0.00% | 16.14倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 384,500円 | +14.5% | -2.3% | 2.34% | 14.07倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 208,800円 | - | - | 0.00% | - | 96.71倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
